Clinilabs vs CMIC HOLDINGS Co., Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/clinilabs/cmicgroup

Category	Clinilabs	CMIC HOLDINGS Co., Ltd.
Listed site	cro	cro
Summary	Clinilabs is the leading CNS-focused CRO with 25+ years of expertise in neurotherapeutic clinical trials, offering Phase 1–4 trial management, early-phase development, clinical research units, and MedTech device expertise across psychiatry, neurology, substance use, and rare CNS disorders.	CMIC HOLDINGS is a Japanese contract research and manufacturing organization providing end-to-end pharmaceutical solutions from non-clinical through post-marketing phases, including consulting, CRO, CDMO, and SMO services.
Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Clinical Trial Services Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy CNS Specialty Services Device & Combination Product Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy
Modalities	Data not yet provided.	Data not yet provided.
Indications	Neurology Psychiatry Rare Disease	Data not yet provided.
Locations	Headquarters, Eatontown, New Jersey, United States Regional Office, New York, New York, United States European Headquarters, Allschwil, Basel Area, Switzerland Regional Office, Paris, Île-de-France, France Regional Office, Beijing, Chaoyang District, China Regional Office, Tokyo, Shinjuku-ku, Japan	Data not yet provided.
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.